(Q37710514)

22 August 2017

1 reference

title

A current update on ADHD pharmacogenomics (English)

1 reference

attention deficit hyperactivity disorder

22 August 2017

1 reference

0 references

author

Mara H. Hutz

series ordinal

3

1 reference

22 August 2017

Christian Kieling

1

0 references

Luis Augusto Rohde

object named as

Luis Augusto Rohde

series ordinal

4

0 references

Júlia Pasqualini Genro

series ordinal

2

object named as

Júlia P Genro

1 reference

22 August 2017

publication date

1 March 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

11

1 reference

22 August 2017

issue

3

1 reference

22 August 2017

page(s)

407-419

1 reference

Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association

22 August 2017

cites work

1 reference

Neurobiology of attention deficit hyperactivity disorder

21 January 2018

1 reference

The pharmacogenomic era: promise for personalizing attention deficit hyperactivity disorder therapy

21 January 2018

1 reference

Attention-deficit/hyperactivity disorder: advancing on pharmacogenomics

21 January 2018

1 reference

Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR.

21 January 2018

1 reference

Candidate gene studies of ADHD: a meta-analytic review

21 January 2018

1 reference

Association of the dopamine transporter gene (DAT1) with poor methylphenidate response

21 January 2018

1 reference

Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder

21 January 2018

1 reference

Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD.

21 January 2018

1 reference

COMT polymorphisms and anxiety-related personality traits

21 January 2018

1 reference

High sibling correlation on methylphenidate response but no association with DAT1-10R homozygosity in Dutch sibpairs with ADHD.

21 January 2018

1 reference

No support for association between the dopamine transporter (DAT1) gene and ADHD.

21 January 2018

1 reference

Pharmacogenetics of methylphenidate response in preschoolers with ADHD.

21 January 2018

1 reference

Dopamine transporter 3'-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate.

21 January 2018

1 reference

Association of dopamine, serotonin, and nicotinic gene polymorphisms with methylphenidate response in ADHD.

21 January 2018

1 reference

Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children.

21 January 2018

1 reference

Pharmacogenetics of methylphenidate response in attention deficit/hyperactivity disorder: association with the dopamine transporter gene (SLC6A3).

21 January 2018

1 reference

Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

21 January 2018

1 reference

Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHD

21 January 2018

1 reference

Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1).

21 January 2018

1 reference

Dopamine transporter gene, response to methylphenidate and cerebral blood flow in attention-deficit/hyperactivity disorder: a pilot study

21 January 2018

1 reference

The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate.

21 January 2018

1 reference

Functional effects of the DAT1 polymorphism on EEG measures in ADHD.

21 January 2018

1 reference

Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder

21 January 2018

1 reference

Dopamine transporter genotype influences the physiological response to medication in ADHD.

21 January 2018

1 reference

SH3 binding domains in the dopamine D4 receptor

21 January 2018

1 reference

Marker gene polymorphisms in hyperkinetic disorder--predictors of clinical response to treatment with methylphenidate?

21 January 2018

1 reference

Dopamine receptor 4 (DRD4) 7-repeat allele predicts methylphenidate dose response in children with attention deficit hyperactivity disorder: a pharmacogenetic study.

21 January 2018

1 reference

Genetic mapping of adrenergic receptor genes in humans

21 January 2018

1 reference

Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

Adrenergic alpha2A receptor gene and response to methylphenidate in attention-deficit/hyperactivity disorder-predominantly inattentive type

21 January 2018

1 reference

Association between homozygosity of a G allele of the alpha-2a-adrenergic receptor gene and methylphenidate response in Korean children and adolescents with attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction

21 January 2018

1 reference

Attention deficit hyperactivity disorder with reading disabilities: preliminary genetic findings on the involvement of the ADRA2A gene

21 January 2018

1 reference

Methylphenidate improves reading performance in children with attention deficit hyperactivity disorder and comorbid dyslexia: an unblinded clinical trial

21 January 2018

1 reference

Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme

21 January 2018

1 reference

Association of the catechol-O-methyltransferase polymorphism with methylphenidate response in a classroom setting in children with attention-deficit hyperactivity disorder

21 January 2018

1 reference

COMT Val108/158Met polymorphism and the modulation of task-oriented behavior in children with ADHD.

21 January 2018

1 reference

Genome-wide association study of response to methylphenidate in 187 children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

Association of norepinephrine transporter gene with methylphenidate response

21 January 2018

1 reference

Association between tryptophan hydroxylase 2, performance on a continuance performance test and response to methylphenidate in ADHD participants

21 January 2018

1 reference

Long-acting methylphenidate has an effect on aggressive behavior in children with attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

MAOA is associated with methylphenidate improvement of oppositional symptoms in boys with attention deficit hyperactivity disorder

21 January 2018

1 reference

Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis

21 January 2018

1 reference

Carboxylesterase 1 gene polymorphism and methylphenidate response in ADHD.

21 January 2018

1 reference

Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study

21 January 2018

1 reference

CYP2D6 and clinical response to atomoxetine in children and adolescents with ADHD.

21 January 2018

1 reference

CYP2D6 metabolizer status and atomoxetine dosing in children and adolescents with ADHD.

21 January 2018

1 reference

A haplotype of the norepinephrine transporter (Net) gene Slc6a2 is associated with clinical response to atomoxetine in attention-deficit hyperactivity disorder (ADHD).

21 January 2018

1 reference

Better reporting of randomised controlled trials: the CONSORT statement

21 January 2018

1 reference

The impact of individual and methodological factors in the variability of response to methylphenidate in ADHD pharmacogenetic studies from four different continents

21 January 2018

1 reference

The D4 dopamine receptor (DRD4) maps to distal 11p close to HRAS

21 January 2018

1 reference

No significant association between response to methylphenidate and genes of the dopaminergic and serotonergic systems in a sample of Brazilian children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

Association of 4-repeat allele of the dopamine D4 receptor gene exon III polymorphism and response to methylphenidate treatment in Korean ADHD children

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/PGS.10.28

1 reference

22 August 2017

1 reference